---
figid: PMC7969395__nihms-1642205-f0002
figtitle: Strategies of targeting cancer cells carrying WT p53, mutant p53, or p53
  deletion
organisms:
- Adenoviridae
- Human papillomavirus
- DNA viruses
- Betapolyomavirus macacae
- Polyomavirus sp.
- Homo sapiens
- Mus musculus
pmcid: PMC7969395
filename: nihms-1642205-f0002.jpg
figlink: /pmc/articles/PMC7969395/figure/F2/
number: F2
caption: Strategies for each type of cancer cells are highlighted in red. Adenovirus-based
  gene therapy, chemo and radiotherapy, MDM32 and MDMX inhibitors can be used to target
  cancer cells carrying wild type p53. Gene therapy, compounds restoring WT conformation,
  HSP inhibitors, immunotherapy, and inhibition of synthetic lethal genes can be used
  for targeting cancer cells carrying mutant p53. For targeting cancer cells with
  p53 deletions, gene therapy and inhibition of synthetic lethal genes can be used.
papertitle: Current Developments of Targeting the p53 Signaling Pathway for Cancer
  Treatment.
reftext: Jing Huang. Pharmacol Ther. ;220:107720-107720.
year: '2021'
doi: 10.1016/j.pharmthera.2020.107720
journal_title: Pharmacology & therapeutics
journal_nlm_ta: Pharmacol Ther
publisher_name: ''
keywords: p53 | tumor suppressor | gain of function | cancer | cancer therapy | immunotherapy
automl_pathway: 0.7056974
figid_alias: PMC7969395__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7969395__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7969395__nihms-1642205-f0002.html
  '@type': Dataset
  description: Strategies for each type of cancer cells are highlighted in red. Adenovirus-based
    gene therapy, chemo and radiotherapy, MDM32 and MDMX inhibitors can be used to
    target cancer cells carrying wild type p53. Gene therapy, compounds restoring
    WT conformation, HSP inhibitors, immunotherapy, and inhibition of synthetic lethal
    genes can be used for targeting cancer cells carrying mutant p53. For targeting
    cancer cells with p53 deletions, gene therapy and inhibition of synthetic lethal
    genes can be used.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - TP63
  - TP73
  - MDM4
  - MDM2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HSP90B2P
  - Trp53
  - Mdm4
  - Mdm2
---
